Cargando…
Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants
OBJECTIVE: ACAN gene variants are an important cause of familial short stature (FSS). Appropriate growth-promoting therapies effectively improve the patient height. Here, we report a therapeutic assessment of cases of seven families of FSS patients with heterozygous ACAN variants. Our findings provi...
Autores principales: | Sun, Jie, Jiang, Lihong, Liu, Geli, Ma, Chen, Zheng, Jiaqi, Niu, Lele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940281/ https://www.ncbi.nlm.nih.gov/pubmed/35330881 http://dx.doi.org/10.3389/fped.2022.819074 |
Ejemplares similares
-
ACAN mutations as a cause of familial short
stature
por: Dateki, Sumito
Publicado: (2017) -
Downregulation of ACAN is Associated with the Growth hormone pathway and Induces short stature
por: Wu, Huiping, et al.
Publicado: (2023) -
Case report: A Chinese boy with facial dysmorphism, immunodeficiency, livedo, and short stature syndrome
por: Jiang, Lihong, et al.
Publicado: (2022) -
High frequency of pathogenic ACAN variants including an intragenic deletion in selected individuals with short stature
por: Stavber, L, et al.
Publicado: (2019) -
Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature
por: Hauer, Nadine N., et al.
Publicado: (2017)